Ticker Symbol: AVHHL
AVITA Medical Inc - Chess Depository Interest
Exchange: OTC MARKETS
Country:
US
Currency:
USD
Asset
Type: ADR
CIK:0001762303
Company Profile
avita medical (http://www.avitamedical.com/) is a publicly listed regenerative medicine company trading on the australian stock exchange (asx:avh) and otc markets (otcqx:avmxy). the company’s lead product, recell® is used in a wide variety of burns, chronic wounds, plastic, reconstructive and cosmetic procedures. recell is patented, ce-marked for europe, tga- registered in australia, and sfda-cleared in china. recell is not available for sale in the united states; in the us recell is an investigational device limited by federal law to investigational use.
Sector: Manufacturing
Industry: Surgical and Medical Instrument Manufacturing
Standard Industrial Classification Code (SIC code): 3841
Address: 28159 Avenue Stanford Ste 220
Website: http://www.avitamedical.com/
CEO: Michael Perry
Tags:
- Health Technology
- Medical Specialties
Pricing
Last Updated: December 31, 1969 07:00 PM EST
Previous Close: -
Change:
-$0.14
(
-6.64%)
Days Range: $2.04 - $2.04
Beta: -
52wk. High: $4.01
52wk. Low: $0.00
Ytd. Change 9561.61%
50 Day Moving Average: $2.50
200 Day Moving Average: $2.99
Shares Outstanding: 59640755
Valuation
Market Cap: 26.0B
PE Ratio: -1.67
EPS (TTM): -1.22
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A